A Comparison of Ezetimibe and Evolocumab for Atherogenic Lipid Reduction in Four Patient Populations: A Pooled Efficacy and Safety Analysis of Three Phase 3 Studies
Abstract Introduction Clinicians, payers, guideline committees, and policymakers support the use of high-intensity statins in patients at high risk for complications of cardiovascular disease (CVD). Guidelines and recommendations provide guidance on next steps for patients with inadequate low-densit...
Na minha lista:
| Principais autores: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Adis, Springer Healthcare
2020-06-01
|
| coleção: | Cardiology and Therapy |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1007/s40119-020-00181-8 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|